FEATURING: Newly Released
Medical Affairs Intelligence Report - Non-Small Cell Lung Cancer (NSCLC) August 2026
Subscribe here
By moving the Medical Affairs from a support to a strategic function, Field Medical Center of Excellence (FMEDCE) helps pharmaceutical and biotechnology organizations anticipate scientific, clinical, and healthcare trends through Medical Affairs Market Research and Strategic Intelligence.
We do not simply ask: “What is happening?” Instead, we provide an answer to: “Why is it happening, what does it mean, and what should Medical Affairs leaders do about it?”
We transform scientific data into strategic insight, helping Medical Affairs leaders make evidence-based decisions about future opportunities, risks, and stakeholder needs.
MEDICAL AFFAIRS MARKET RESEARCH: What is it and why it’s essential?
Medical affairs market research is not about forecasting sales but is about understanding how scientific evidence, stakeholder needs, clinical practice, and healthcare systems are evolving. Currently, medical affairs function is at the center of several major dynamic and ever-changing forces: scientific innovation, AI, clinical practice, healthcare systems, and stakeholder expectations. These forces evolve faster than many organizations can even interpret. Considering this, how does your decision making take into account modern industry trends?
Medical affairs market research helps companies answer the following key questions:
Where is the current science going and how is it evolving?
Which evidence gaps still exist in the current treatment paradigms?
What do physicians actually need?
Which competitors really matter?
What medical capabilities should we be investing in to accommodate current trends?
While traditional market research asks “What will physicians prescribe in a given scenario?”, the key question that drives medical affairs market research is “What scientific, clinical, healthcare system, and stakeholder trends are shaping the future evidence and engagement needs of healthcare?"
Medical affairs market research brings the power to transform scientific and healthcare intelligence into actionable business insights for pharmaceutical and biotechnology organizations at any stage of their drug’s lifecycle. Most “market research” entities may understand markets but not science, while most medical affairs professionals understand science but do not package insights into strategic business intelligence. At Field Medical Center of Excellence, we are dedicated to closing this gap.
Medical Affairs Market Research is the systematic collection, analysis, and interpretation of scientific, clinical, stakeholder, and healthcare ecosystem data to identify emerging trends, evidence needs, and strategic opportunities that impact medical affairs decision-making.
Our Approach To Medical Affairs Market Research
At Field Medical Center of Excellence (FMEDCE), we deliver six medical affairs market research based endpoints:
1. Scientific Trends & Intelligence research includes monitoring includes (not limited to) on emerging therapeutic modalities, clinical trials, publications, congresses, and new (emerging) mechanisms of action. The main questions we aim to address are: 1) Where is science moving and what new science is emerging?, 2) Which therapeutic areas are accelerating, and which disease areas are attracting research?, 3) Which new biomarkers are becoming clinically actionable?, 4) What new clinical endpoints are becoming relevant?, 5) What are current real-world evidence (RWE) applications?, 6) What is the current status of using decentralized clinical trials?
2. Stakeholder Intelligence encompasses research on a wide variety of insights from stakeholders that medical affairs serves: physicians, APPs (NPs/PAs), pharmacists, patients, payers, and health systems. The questions that we aim to answer in our research are: 1) What information do HCPs still need and what are stakeholders asking?, 2) What evidence gaps exist?, 3) How are KOL expectations changing?, and 4) Which channels are clinicians utilizing for medical education.
3. Evidence Generation Trends Intelligence is based on monitoring RWE studies, registries, HEOR, and guideline changes and accommodations. It further requires us to monitor pragmatic studies and external data partnerships. The questions that we aim to answer are: 1) Where are companies investing?, 2) What evidence is required or missing?, 3) What evidence is expected post-launch?, 4) Which study designs are becoming a standard?, 5) What evidence actually influences clinical decisions?
4. Competitive Medical Intelligence encompasses competitor publications, congress activity, investigator-sponsored trials, and medical personnel hiring. The two main questions we aim to answer are: 1) Where are competitors investing; and 2) Which new scientific narratives are emerging?
5. Medical Affairs Operational Trends investigate and monitor trends on AI-enabled medical information, MSL digital engagement, omnichannel medical communications, medical analytics, and field medical effectiveness. The questions we aim to answer are: 1) How are medical affairs organizations evolving?, 2) What capabilities are growing?, 3) Which functions are being centralized or outsourced?
6. Future Trends & Foresights is based on monitoring trends in AI, digital health, diagnostics, and regulatory changes. We aim to answer the following questions in our research: 1) What will medical affairs look like in five years?; and 2) Which capabilities need investment?
We are here to help you transform the medical affairs function into the the scientific intelligence engine of the entire organization!
Field Medical Center of Excellence supports organizations by identifying:
1. Future evidence needs
2. Emerging stakeholder trends
3. Scientific adoption patterns
4. Healthcare ecosystem changes
Field Medical Center of Excellence offers the following Intelligence Products to our customers:
QUARTERLY MEDICAL AFFAIRS TRENDS REPORT
o Top emerging trends
o New evidence generation approaches
o Stakeholder shifts
o Competitive intelligence
Subscribe here for our Quarterly Medical Affairs Trends Report
ONCOLOGY MEDICAL INTELLIGENCE BRIEFINGS
Monthly reports cover solid tumors, hematology, ADCs, and immunotherapy.
Subscribe here for our Monthly Oncology Medical Intelligence Briefings
MEDICAL AFFAIRS OPPORTUNITY ASSESSMENTS
This is intended for our biotech clients. Questions addressed in our Medical Affairs Opportunity Assessments reports are: 1) What evidence will be (is still) needed)?; 2) What MSL structure is required?; and 3) What KOL engagement strategy makes sense?
Subscribe here for our Medical Affairs Opportunity Assessments.
EXECUTIVE BRIEFINGS
One-page reports for leaders. This format includes trends, drivers, business implications, and recommended actions.
Subscribe here for our Executive Briefings.